SCHEMBL20201159

SCHEMBL20201159

COC[C@@H](C)NC(=O)c1nc[nH]c1C(=O)N[C@H]1CC[C@H](C(=O)Nc2ccc(F)cc2Cl)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ ALDH1A1 P00352 4/20 0.41
▸ POLB P06746 5/20 0.40
▸ NPSR1 Q6W5P4 5/20 0.40
▸ MAPT P10636 4/20 0.40
▸ MAPK1 P28482 4/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ GPR55 Q9Y2T6 1/20 0.38
▸ DRD4 P21917 3/20 0.38
▸ CHRM4 P08173 1/20 0.37
▸ CCNA2 P20248 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ GSK3A P49840 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ NTSR1 P30989 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.36
▸ DRD3 P35462 1/20 0.36
▸ ALPL P05186 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20201158 1.00 MEN1 (0.41) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL20201157 1.00 MEN1 (0.41) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL18216439 0.91 MEN1 (0.42) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL18216418 0.91 KMT2A (0.44) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL20201145 0.91 HPGD (0.41) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL18216483 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL20201154 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL20201155 0.88 MEN1 (0.41) MEN1KMT2AALDH1A1POLBNPSR1
SCHEMBL20201142 0.87 HPGD (0.49) MEN1KMT2AALDH1A1POLBMAPT
SCHEMBL20205023 0.87 HPGD (0.40) MEN1KMT2AALDH1A1POLBNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 — — US disclosed
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148418-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES C1R, C9, C1S MEN1 56/4885KMT2A 3502/4885ALDH1A1 2194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback